莱伯泰科(688056) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2025 was ¥92,908,661.34, a decrease of 4.22% compared to the same period last year[2] - Total profit for the quarter was ¥13,260,810.45, reflecting an increase of 6.73% year-over-year[2] - Net profit attributable to shareholders was ¥11,453,748.67, up by 1.76% from the previous year[2] - Total operating revenue for the first three quarters of 2025 was CNY 284,872,833.06, a decrease of 8.5% compared to CNY 311,093,406.06 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 32,546,867.25, a decline of 7.2% from CNY 35,096,522.16 in 2024[19] - Earnings per share for the first three quarters of 2025 was CNY 0.49, compared to CNY 0.53 in the same period of 2024[20] Cash Flow - The net cash flow from operating activities for the quarter was ¥10,429,408.97, a significant increase of 866.18% compared to the same period last year[2] - Net cash flow from operating activities was 2,583,396.37, a significant improvement from a negative cash flow of -3,051,848.65 in the previous period[22] - Total cash inflow from investment activities reached 1,035,641,465.80, compared to 901,770,270.89 in the prior period, indicating a growth of approximately 14.8%[22] - Cash outflow for investment activities was 1,033,124,451.17, up from 964,282,001.85, reflecting an increase of about 7.1%[22] - Net cash flow from investment activities was 2,517,014.63, a recovery from a negative cash flow of -62,511,730.96 in the previous period[22] - Cash received from tax refunds was 1,405,361.02, an increase from 1,165,909.27 in the previous period[22] - Cash received from other operating activities was 8,047,596.89, down from 14,536,511.58, indicating a decline of approximately 44.7%[22] - Cash paid for employee compensation was 91,718,610.65, a decrease from 97,099,560.70, reflecting a reduction of about 5.5%[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥909,209,199.94, down 4.87% from the end of the previous year[3] - Current assets totaled RMB 733,318,726.56, down from RMB 767,512,121.41, indicating a decrease of about 4.46%[14] - Total liabilities decreased to RMB 101,674,755.51 from RMB 133,659,707.59, a reduction of about 24.0%[15] - Total liabilities decreased from CNY 138,123,645.32 in 2024 to CNY 105,036,189.12 in 2025, a reduction of approximately 23.9%[16] - Total equity attributable to shareholders decreased from CNY 817,588,631.13 in 2024 to CNY 804,173,010.82 in 2025, a decline of about 1.6%[16] Research and Development - Research and development expenses totaled ¥11,700,309.23, accounting for 12.59% of revenue, a decrease of 0.84 percentage points year-over-year[3] - Research and development expenses for the first three quarters of 2025 were CNY 35,316,884.16, down 6.5% from CNY 37,984,443.96 in 2024[19] Shareholder Information - The company held 674,222 shares in its repurchase account, accounting for 1.00% of the total share capital[12] - The top shareholder, Beijing LabTech Consulting Co., Ltd., holds 32.84% of the shares, while LabTech Holdings, Inc. holds 23.90%[11] Other Financial Metrics - The weighted average return on equity was 1.43%, an increase of 0.04 percentage points compared to the previous year[3] - Non-recurring gains and losses amounted to ¥2,805,474.93 for the quarter[6] - Other comprehensive income after tax for the first three quarters of 2025 was CNY -2,232,709.20, compared to CNY -1,072,568.64 in 2024[20] - Deferred income tax liabilities increased from CNY 997,501.46 in 2024 to CNY 1,208,474.28 in 2025, an increase of approximately 21.1%[16] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may impact financial reporting[24]